Johnson Matthey (LON: JMAT) Shares Indicate Early 14% Drop After £1.325bn Honeywell Deal Revision

Johnson Matthey (LON: JMAT) Shares Indicate Early 14% Drop After £1.325bn Honeywell Deal Revision

Johnson Matthey PLC (LON: JMAT) shares sank in early Monday trading, sliding to 1,972p after a sharp single-session drop of 332p, as investors digested revised terms on the company’s agreed sale of its Catalyst Technologies business to Honeywell. The move pulled the stock well below the prior close of 2,304p and pushed it back toward the lower end of its recent trading band.

The sell-off came as markets focused on a meaningful reset to the transaction value and the timetable for completing the deal. Johnson Matthey’s Catalyst Technologies unit designs and supplies catalysts and process technology used across refining, petrochemicals and energy transition applications, and the disposal has been a central plank of the group’s strategy to streamline operations and concentrate capital on targeted core areas.

Deal value cut to £1.325 billion

Under the amended agreement, Honeywell will acquire Johnson Matthey’s Catalyst Technologies business for an enterprise value of £1.325 billion, down from the original £1.8 billion headline figure agreed last year. The revised value reflects Catalyst Technologies’ trading performance through 2025/26, including the deferral of certain sustainable solutions licensing projects and softer profitability in catalysts supply amid a tougher market backdrop.

Honeywell has framed the acquisition as a strategic fit with its process technology footprint, aiming to broaden its installed base across refining and petrochemical customers and add capability in renewable fuels, while also benefiting from aftermarket service demand over the life of installed assets. Honeywell’s announcement of the amended terms is available via its deal update release.

Timeline extended to late August 2026

The deal timeline has also been pushed out. The long stop date has moved to 21 July 2026, with an option to extend further to 21 August 2026 if specific conditions are met and only certain antitrust approvals remain outstanding. Both parties have indicated an expectation that the transaction will complete by the end of August 2026, subject to customary closing conditions and regulatory clearance.

For Johnson Matthey shareholders, the new timetable matters because it sets the pace for a cash return plan tied to closing. The market reaction suggests investors had been pricing in a quicker completion and a higher value outcome, and the amended terms forced a rapid repricing of that set-up.

£1 billion shareholder return plan remains the core equity hook

Johnson Matthey now expects to return around £1.0 billion of net proceeds to shareholders following completion, structured as an £800 million special dividend with share consolidation and a £200 million on-market share buyback programme. While the revised sale value reduces the overall proceeds compared with earlier expectations, the planned distribution remains substantial relative to the company’s current equity value and is likely to stay a key focus for income and event-driven investors.

In trading, the stock showed a wide intraday range as investors rebalanced around the new numbers. The shares traded between roughly 1,903p and 2,006p in the early window, highlighting the uncertainty around near-term positioning as the market re-maps the value of the remaining Johnson Matthey portfolio once Catalyst Technologies exits.

Turnaround narrative shifts, but does not disappear

The Catalyst Technologies disposal has been part of a broader push to reshape Johnson Matthey into a simpler, more cash-focused group. The company has signalled that it remains on track to deliver 2025/26 performance in line with guidance, including underlying operating profit growth toward the higher end of a mid single-digit range and stronger free cash flow versus the prior year.

Even so, the scale of the price reduction highlighted the sensitivity of large industrial technology deals to project timing, customer investment cycles and approval pathways. With the sale now priced to reflect a tougher operating environment, the market’s next test becomes execution: the cadence of approvals, confirmation of closing conditions, and clarity on the mechanics and timing of the special dividend and buyback once the transaction completes.

At 1,972p, the shares sit below the prior close and meaningfully off the 2,434p 52-week high, though still above the 1,131p 52-week low. That positioning suggests the re-rating achieved since the initial sale announcement has been dented, but not erased. The next legs for the stock are likely to be driven less by speculation and more by hard milestones: regulatory sign-offs, closing certainty, and the cash return pathway.


You May Also Like

Wall Street Futures Fall as Nasdaq Drops After Trump’s 15% Tariff Move